Narcolepsy
European Commission grants marketing approval of oral solution for treating cataplexy
Published in Medical Letter on the CDC and FDA, January 8th, 2006
Xyrem is marketed in the European Union by UCB, which announced the product's availability in Germany.
Narcolepsy is a debilitating neurological disorder. Cataplexy is a typical symptom of narcolepsy, second in frequency only to excessive daytime sleepiness. Cataplexy is a sudden loss of control over voluntary muscles, usually triggered by emotions such as amusement, anger, arousal or fear. Severe cataplexy attacks can cause...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Lyme Disease
Report compares multiplex assays for detecting Borrelia in Ixodes nymphs - Medical Devices
U.S. FDA uses judgment in applying standards for medical devices - Tick-Borne Disease
Robotic method for high-throughput molecular testing of ticks has been developed - Anti-Infectives
U.S. FDA clears the ON-Q SilverSoaker antimicrobial catheter - Antibiotic Resistance
Report reviews evolution of antibiotic resistance in S. pneumoniae in Brittany - Apoptosis
Retinol induces cytochrome c release from rat liver mitochondria - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
